Drug Profile
Polyclonal antibody Candistat G
Alternative Names: Candistat GLatest Information Update: 02 Dec 1998
Price :
$50
*
At a glance
- Originator GalaGen
- Class Antifungals; Polyclonal antibodies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Candidiasis
Most Recent Events
- 02 Dec 1998 Discontinued-II for Candidiasis in Sweden (PO)
- 28 Aug 1997 New profile
- 28 Aug 1997 Phase-II clinical trials for Candidiasis in Sweden (PO)